Europe, Middle East & Africa Substance Abuse Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Europe, MEA Substance Abuse Treatment Market is Segmented by Abuse Type (Alcohol Dependence, Tobacco/Nicotine Addiction, Opioid Addiction, Other Abuse Types), Treatment (Alcohol Addiction Treatment, Tobacco/Nicotine Addiction Treatment, Drug Abuse Treatment, Other Treatment Types), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels), and Geography (Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Middle East and Africa (GCC, South Africa, Rest of Middle East and Africa)). The report offers the value (in USD million) for the above segments.

Europe, Middle East & Africa Substance Abuse Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Europe, MEA Substance Abuse Treatment Industry Overview

The market is highly competitive and consists of several major players. Companies like Alkermes PLC, Abbvie (Allergan), GSK plc, Mallinckrodt LLC, Viatris, Pfizer Inc., Purdue Pharma LP, Sanofi, and Teva Pharmaceutical Industries Ltd, among others, hold a substantial share in the market studied.

Europe, MEA Substance Abuse Treatment Market Leaders

  1. Mallinckrodt LLC

  2. Indivior PLC

  3. Alkermes PLC

  4. Viatris

  5. GSK plc

  6. *Disclaimer: Major Players sorted in no particular order
Europe, MEA Substance Abuse Treatment Market Concentration

Europe, Middle East and Africa Substance Abuse Treatment Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?